[1]Tannemaat M R, Huijbers M G, Verschuuren J J G M. Myasthenia gravis-pathophysiology, diagnosis, and treatment[J]. Handb Clin Neurol, 2024, 200: 283-305.
[2]Bubuioc A M, Kudebayeva A, Turuspekova S, et al. The epidemiology of myasthenia gravis[J]. J Med Life, 2021, 14(1): 7-16.
[3]Truffault F, De Montpreville V, Eymard B, et al. Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review[J]. Clin Rev Allergy Immunol, 2017, 52(1): 108-124.
[4]Chung H Y, Shin H Y, Choi Y C, et al. Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma[J]. Eur J Neurol, 2024, 31(2): e16119.
[5]Sarkkinen J, Dunkel J, Tuulasvaara A, et al. Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy[J]. Mod Pathol, 2022, 35(9): 1168-1174.
[6]Suzuki T, Hishida T, Suzuki S, et al. Clinicopathological predictors of postoperative long-term myasthenic status in resected thymoma with myasthenia gravis[J]. Surg Today, 2024, 54(7): 787-794.
[7]Cron M A, Maillard S, Villegas J, et al. Thymus involvement in early-onset myasthenia gravis[J]. Ann N Y Acad Sci, 2018, 1412(1): 137-145.
[8]Furuya T, Tando S, Ogi H, et al. Distribution of ectopic germinal centers in thymic epithelial tumors and their relationship with thymic involution[J]. Cancer Sci, 2025, 116(11): 3209-3219.
[9]Lefeuvre C M, Payet C A, Fayet O M, et al. Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers[J]. J Autoimmun, 2020, 106: 102337.
[10]Coppola D, Nebozhyn M, Khalil F, et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling[J]. Am J Pathol, 2011, 179(1): 37-45.
[11]Germain C, Gnjatic S, Tamzalit F, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer[J]. Am J Respir Crit Care Med, 2014, 189(7): 832-844.
[12]Silina K, Kroeger D. Editorial: immune outposts on the inflammatory frontier: tertiary lymphoid structures as targets for immunotherapy of cancer and autoimmunity[J]. Front Immunol, 2019, 10: 993.
[13]Yasumizu Y, Kinoshita M, Zhang M J, et al. Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis-associated thymoma[J]. Cell Rep, 2024, 43(9): 114677.
[14]Choi J, Crotty S, Choi Y S, et al. Cytokines in follicular helper T cell biology in physiologic and pathologic conditions[J]. Immune Netw, 2024, 24(1): e8.
[15]Yasumizu Y, Ohkura N, Murata H, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma[J]. Nat Commun, 2022, 13(1): 4230.
[16]Niu L, Jiang J, Yin Y, et al. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma[J]. Clin Exp Pharmacol Physiol, 2020, 47(6): 989-996.
|